CanadaApotex Inc. is recalling APO‑TRAVOPROST‑TIMOP PQ ophthalmic solution (travoprost 0.004% / timolol 0.5%), Market Authorization DIN 02415305, lot VH4975. The lot is being recalled because it is missing the documented justification for the results obtained. Verify whether you have the affected lot, consult your healthcare provider before discontinuing use or for health concerns, contact Apotex with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers
Companies: Apotex Inc., 150 Signet Drive, Toronto, Ontario, M9L 1T9.
How to identify it
Brand: APO-TRAVOPROST-TIMOP PQ; Product Name: APO-TRAVOPROST-TIMOP PQ; Market Authorization: DIN 02415305; Dosage Form: Solution; Strength: Travoprost - Timolol (Timolol Maleate) 0.004 % / 0.5%; Lot: VH4975
The hazard
The affected lot is missing the documented justification for the results obtained.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)